PPT-Ticagrelor compared with clopidogrel in patients with acute

Author : tatyana-admore | Published Date : 2016-06-18

PLAT elet Inhibition and patient O utcomes trial Outcomes in patients with a Planned Invasive Strategy The PLATO trial was funded by AstraZeneca Invasive PLATO

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/367440" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Ticagrelor compared with clopidogrel in ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Ticagrelor compared with clopidogrel in patients with acute: Transcript

EVIDENCE-BASED MEDICINE FOR POST MI CARE

Canadian Diabetes Association Clinical Practice Guidelines

Long-Term Tolerability of

Prasugrel vs ticagrelor in acute coronary syndromes

EVIDENCE-BASED MEDICINE FOR POST MI CARE

Antiplatelet Therapy for Secondary Prevention in the First Year Following

Antiplatelet Agents Mohammad Sistanizad

Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC

Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients

Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily,

Cangrelor in Patients with Coronary Artery Disease Pre-treated with Ticagrelor: The Switching

One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes:

Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,